In last trading session, OKYO Pharma Limited (NASDAQ:OKYO) saw 4.0 million shares changing hands with its beta currently measuring -0.28. Company’s recent per share price level of $1.07 trading at $0.03 or 3.28% at ring of the bell on the day assigns it a market valuation of $36.26M. That closing price of OKYO’s stock is at a discount of -77.57% from its 52-week high price of $1.90 and is indicating a premium of 24.3% from its 52-week low price of $0.81. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 43860.0 shares which gives us an average trading volume of 58.80K if we extend that period to 3-months.

For OKYO Pharma Limited (OKYO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.

OKYO Pharma Limited (NASDAQ:OKYO) trade information

Upright in the green during last session for gaining 3.28%, in the last five days OKYO remained trading in the green while hitting it’s week-highest on Wednesday, 01/29/25 when the stock touched $1.07 price level, adding 27.7% to its value on the day. OKYO Pharma Limited’s shares saw a change of -6.95% in year-to-date performance and have moved 3.25% in past 5-day. OKYO Pharma Limited (NASDAQ:OKYO) showed a performance of 0.00% in past 30-days. Number of shares sold short was 0.21 million shares which calculate 2.26 days to cover the short interests.

OKYO Pharma Limited (OKYO) estimates and forecasts

Statistics highlight that OKYO Pharma Limited is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -14.40% of value to its shares in past 6 months, showing an annual growth rate of 29.82% while that of industry is 16.20. Apart from that, the company came raising its revenue forecast for fiscal year 2025.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -126.59% during past 5 years.